BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor

  MyoKardia designed an exploratory digital health substudy as part of the Phase 2 PIONEER-HCM trial of mavacamten (formerly MYK-461) to determine if an optical biosensor, similar to those that monitor heart rate on commercially available fitness trackers, could identify patients with oHCM.

  November 14, 2017

   · 

  5 min read
• Business

  CohBar Announces Third Quarter 2017 Financial Results

  CohBar had cash and investments of $10,342,242 on September 30, 2017, compared to $8,686,420 on December 31, 2016.

  November 14, 2017

   · 

  12 min read
• Lone Star Bio

  XBiotech Announces Presentation of Novel Findings for MABp1 in the Prevention of Coronary Thrombosis at the American Heart Association Scientific Sessions

  IL-1a Neutralizing Antibody MABp1 Found to Block NETs’ Ability to Increase Endothelial Activation and Thrombogenicity

  November 14, 2017

   · 

  5 min read
• Business

  Dr. Jonathan Eisen Joins Zymo Research’s Scientific Advisory Board

  The Zymo Research Board of Directors has announced the appointment of Dr. Jonathan Eisen, Biologist, to its Scientific Advisory Board, effective immediately.

  November 14, 2017

   · 

  3 min read
• Business

  POS Bio-Sciences Announces New Marketing Partnership with William Joseph Communications

  William Joseph is a fully-integrated marketing agency that empowers local resource and technology companies, non-profits, and entrepreneurs to change the world.

  November 14, 2017

   · 

  2 min read
• Business

  Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update

  Total Revenue increased 21%, from $535,334 in Q3 2016 to $646,061

  November 14, 2017

   · 

  20 min read
• Business

  Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights

  As of September 30, 2017, Pluristem had $21.3 million in cash and cash equivalents, bank deposits, restricted deposits and marketable securities.

  November 14, 2017

   · 

  7 min read
• Business

  Deciphera Pharmaceuticals Announces Third Quarter 2017 Financial Results and Corporate Highlights

  As of September 30, 2017, Deciphera Pharmaceuticals reported cash and cash equivalents of $82.1 million.

  November 14, 2017

   · 

  10 min read
• American Academy of Ophthalmology Release: Stem Cell Therapy Shows Promise for Common Cause of Blindness

  Results from two early clinical trials show that it may be possible to use human embryonic stem cells as treatment for the dry form of macular degeneration, according to presentations given today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

  November 14, 2017

   · 

  4 min read
• Business

  EyeGate Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

  EyeGate’s revenue for the third quarter of 2017 totaled $0.075 million, compared with $0.274 million in the third quarter of 2016.

  November 14, 2017

   · 

  6 min read